Bayer Aktiengesellschaft (ETR:BAYN) Shares Down 2.9% – Should You Sell?

Shares of Bayer Aktiengesellschaft (ETR:BAYN) dropped 2.9% during trading on Thursday . The stock traded as low as €47.53 and last traded at €47.71. Approximately 2,371,699 shares changed hands during trading, The stock had previously closed at €49.12.

Bayer Aktiengesellschaft Price Performance

The stock has a fifty day moving average of €41.10 and a 200-day moving average of €40.94. The company has a quick ratio of 0.72, a current ratio of 1.06 and a debt-to-equity ratio of 134.81. The firm has a market capitalization of $48.92 billion, a P/E ratio of -55.60, a PEG ratio of 36.39 and a beta of 0.83.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health.